Results for "Understanding Pharmaceutical Distribution"
HDA Statement on National Biodefense Strategy and Implementation Plan
The Healthcare Distribution Alliance (HDA) released the following statement in response to the Biden-Harris administration’s National Biodefense Strategy and Implementation Plan.
HDA Names Hannah Seitzinger Director of State Government Affairs
The Healthcare Distribution Alliance (HDA) announces the addition of Hannah Seitzinger as Director, State Government Affairs. In this role, Ms. Seitzinger will represent HDA’s healthcare distributor members in multiple states across the Midwest and report to Leah Lindahl, Vice President, State Government Affairs.
Faces of the Supply Chain: Distribution Sector Problem Solving and Cold Chain Capabilities
In the latest installment of HDA’s Faces of the Supply Chain series, HDA asked industry leaders to reflect on the role of healthcare distribution sector professionals as they navigate everyday challenges and adapt to evolving best practices as novel treatments emerge.
In part one of our two-part blog series, HDA is recapping the valuable perspectives shared during our conversations conducted at the 2024 Distribution Management Conference.
The First 90 Days: US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19
Developed in collaboration with Deloitte Consulting LLP, this report examines the role that the supply chain played in delivering medicines safely and efficiently to patients during the unprecedented early days of the COVID-19 pandemic.
